The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
"Slowing the aging process of aging by tweaking the body’s metabolism", Prof. Leonard P. Guarente, Novartis Professor of Biology, MIT & co-founder, Elysium Health
JC Gutiérrez-Ramos, President and CEO, Synlogic
Erik Vogan, PhD, MBA, Program Director, MIT Corporate Relations Industrial Liaison Program
P&G is seeking startups for innovative consumer experiences: 1) Making a Sustainable Lifestyle Effortless 2) AI Technologies for Digital Expert Advisors with conversational AI and hybrid human-ML, 3) Transformative Transactions including sourcing, manufacturing, distribution, and autonomous supply chain, 4) Automation of Daily In-Home Consumer Tasks, and 5) Enabling Breakthrough Growth for Omnichannel Brands.
Vincent Ling, Senior Director, Materials and Innovation, Takeda
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
"Trends in automotive robotics," Alexander Zak, Director Corporate R&D, Magna International